Pfizer India (PFIZER) Q2 25/26 earnings summary

Executive summary

• Unaudited financial results for the quarter and half year ended September 30, 2025, were approved by the Board on November 12, 2025.

• Financials prepared in accordance with Ind AS and reviewed by statutory auditors with no modifications.

Financial highlights

• Revenue from operations for Q2 FY26 was ₹642.34 crore, up from ₹603.05 crore in Q1 FY26 and ₹588.59 crore in Q2 FY25.

• Net profit for Q2 FY26 was ₹189.02 crore, compared to ₹191.75 crore in Q1 FY26 and ₹158.35 crore in Q2 FY25.

• Earnings per share for Q2 FY26 stood at ₹41.32, compared to ₹41.91 in Q1 FY26 and ₹34.61 in Q2 FY25.

• Total comprehensive income for H1 FY26 was ₹378.94 crore, up from ₹307.99 crore in H1 FY25.

Outlook and guidance

• No forward-looking guidance or outlook was provided in the reviewed period.